However, theres an important caveat: most of the data comes from animal research, not human clinical trials
MMA levels werent measured (Seal, 2000)
Great Potential in the Treatment of Metabolic Diseases With the high prevalence of metabolic diseases worldwide, 5-amino-1-methylquinolinium has shown outstanding performance in animal models of obesity, glucose metabolism disorders, fatty liver disease and other conditions
A common dose is 1000 mcg daily, given either intramuscularly (IM) or subcutaneously
Research HO, Quality Research, and Peptide Crafters met USP expectations for chemical parameters only (%BA and pH) but were not tested for sterility or endotoxins in the PTDS dataset
others use them occasionally for a boost.